143 related articles for article (PubMed ID: 18193094)
1. Difference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines.
Sasaki H; Hayakawa J; Terai Y; Kanemura M; Tanabe-Kimura A; Kamegai H; Seino-Noda H; Ezoe S; Matsumura I; Kanakura Y; Sakata M; Tasaka K; Ohmichi M
Oncogene; 2008 Apr; 27(19):2737-45. PubMed ID: 18193094
[TBL] [Abstract][Full Text] [Related]
2. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
[TBL] [Abstract][Full Text] [Related]
3. Molecular determinants for the tissue specificity of SERMs.
Shang Y; Brown M
Science; 2002 Mar; 295(5564):2465-8. PubMed ID: 11923541
[TBL] [Abstract][Full Text] [Related]
4. Estrogens and epithelial ovarian cancer.
Cunat S; Hoffmann P; Pujol P
Gynecol Oncol; 2004 Jul; 94(1):25-32. PubMed ID: 15262115
[TBL] [Abstract][Full Text] [Related]
5. Gene expression changes induced by estrogen and selective estrogen receptor modulators in primary-cultured human endometrial cells: signals that distinguish the human carcinogen tamoxifen.
Pole JC; Gold LI; Orton T; Huby R; Carmichael PL
Toxicology; 2005 Jan; 206(1):91-109. PubMed ID: 15590111
[TBL] [Abstract][Full Text] [Related]
6. Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature.
Olivier S; Close P; Castermans E; de Leval L; Tabruyn S; Chariot A; Malaise M; Merville MP; Bours V; Franchimont N
Mol Pharmacol; 2006 May; 69(5):1615-23. PubMed ID: 16497877
[TBL] [Abstract][Full Text] [Related]
7. The effects of the selective estrogen receptor modulators, methyl-piperidino-pyrazole (MPP), and raloxifene in normal and cancerous endometrial cell lines and in the murine uterus.
Davis AM; Ellersieck MR; Grimm KM; Rosenfeld CS
Mol Reprod Dev; 2006 Aug; 73(8):1034-44. PubMed ID: 16688783
[TBL] [Abstract][Full Text] [Related]
8. Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters.
Cheng AS; Jin VX; Fan M; Smith LT; Liyanarachchi S; Yan PS; Leu YW; Chan MW; Plass C; Nephew KP; Davuluri RV; Huang TH
Mol Cell; 2006 Feb; 21(3):393-404. PubMed ID: 16455494
[TBL] [Abstract][Full Text] [Related]
9. Both estrogen and raloxifene protect against beta-amyloid-induced neurotoxicity in estrogen receptor alpha-transfected PC12 cells by activation of telomerase activity via Akt cascade.
Du B; Ohmichi M; Takahashi K; Kawagoe J; Ohshima C; Igarashi H; Mori-Abe A; Saitoh M; Ohta T; Ohishi A; Doshida M; Tezuka N; Takahashi T; Kurachi H
J Endocrinol; 2004 Dec; 183(3):605-15. PubMed ID: 15590986
[TBL] [Abstract][Full Text] [Related]
10. Raloxifene induces nucleolar translocation of the estrogen receptor.
Gushima M; Kawate H; Ohnaka K; Nomura M; Takayanagi R
Mol Cell Endocrinol; 2010 May; 319(1-2):14-22. PubMed ID: 20083158
[TBL] [Abstract][Full Text] [Related]
11. Differential actions of estrogen and SERMs in regulation of the actin cytoskeleton of endometrial cells.
Flamini MI; Sanchez AM; Goglia L; Tosi V; Genazzani AR; Simoncini T
Mol Hum Reprod; 2009 Oct; 15(10):675-85. PubMed ID: 19541800
[TBL] [Abstract][Full Text] [Related]
12. Estradiol-induced ezrin overexpression in ovarian cancer: a new signaling domain for estrogen.
Song J; Fadiel A; Edusa V; Chen Z; So J; Sakamoto H; Fishman DA; Naftolin F
Cancer Lett; 2005 Mar; 220(1):57-65. PubMed ID: 15737688
[TBL] [Abstract][Full Text] [Related]
13. Effects of pharmacological concentrations of estrogens on growth of 3AO human ovarian cancer cells.
Li ZB; Chen YX; Zhao JY; Lu J
Yi Chuan Xue Bao; 2006 Sep; 33(9):782-92. PubMed ID: 16980124
[TBL] [Abstract][Full Text] [Related]
14. Effects of tamoxifen and raloxifene on normal human endometrial cells in an organotypic in vitro model.
Bläuer M; Heinonen PK; Rovio P; Ylikomi T
Eur J Pharmacol; 2008 Sep; 592(1-3):13-8. PubMed ID: 18638473
[TBL] [Abstract][Full Text] [Related]
15. Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment.
Sirianni R; Zolea F; Chimento A; Ruggiero C; Cerquetti L; Fallo F; Pilon C; Arnaldi G; Carpinelli G; Stigliano A; Pezzi V
J Clin Endocrinol Metab; 2012 Dec; 97(12):E2238-50. PubMed ID: 23074235
[TBL] [Abstract][Full Text] [Related]
16. Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer.
Walker G; MacLeod K; Williams AR; Cameron DA; Smyth JF; Langdon SP
Gynecol Oncol; 2007 Sep; 106(3):461-8. PubMed ID: 17624412
[TBL] [Abstract][Full Text] [Related]
17. Effects of the antiestrogens tamoxifen and raloxifene on the estrogen receptor transactivation machinery.
Glaeser M; Niederacher D; Djahansouzi S; Hanstein B; Dittrich R; Beckmann MW; Fasching PA; Ackermann S
Anticancer Res; 2006; 26(1B):735-44. PubMed ID: 16739346
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma.
Sonpavde G; Okuno N; Weiss H; Yu J; Shen SS; Younes M; Jian W; Lerner SP; Smith CL
Urology; 2007 Jun; 69(6):1221-6. PubMed ID: 17572228
[TBL] [Abstract][Full Text] [Related]
19. Growth response of colon cancer cell lines to selective estrogen receptor modulators.
Picariello L; Fiorelli G; Martineti V; Tognarini I; Pampaloni B; Tonelli F; Brandi ML
Anticancer Res; 2003; 23(3B):2419-24. PubMed ID: 12894523
[TBL] [Abstract][Full Text] [Related]
20. Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells.
Scafoglio C; Ambrosino C; Cicatiello L; Altucci L; Ardovino M; Bontempo P; Medici N; Molinari AM; Nebbioso A; Facchiano A; Calogero RA; Elkon R; Menini N; Ponzone R; Biglia N; Sismondi P; De Bortoli M; Weisz A
J Cell Biochem; 2006 Aug; 98(5):1163-84. PubMed ID: 16514628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]